Skip to content
Guidance for ages 16–25 and their familiesNeed help now?
Adolescent RecoveryUnderstanding. Care. A way forward.
Menu

Addiction and substance use

Prescription Medication Concerns in Ages 16–25

Understand prescribed use, dependence and misuse, prepare for a medication review and seek safe support without abrupt changes or self-directed detox.

For ages 16–25Educational guidanceClinical review pending

1,603 article-body words · Updated 22 September 2026

In this guide
  1. Dependence and addiction
  2. Preparing for a review
  3. Urgent care
  4. ADHD care and academic pressure
  5. Ages 16–17
  6. Ages 18–25
  7. Common questions

Concerns about prescription medication need a careful conversation, not an automatic label of addiction. Taking a medicine as prescribed, experiencing physical dependence, having side effects and misusing medication are different situations that can overlap but should not be treated as identical. The useful first step is a review with an appropriate prescriber or healthcare professional, including an accurate account of what is being taken and why. [1]

For older teenagers and young adults, medication questions may involve attention, sleep, anxiety, pain or academic pressure. This guide explains how to prepare for assessment and seek support without making abrupt changes or following a home detox plan.

Clarify the concern before choosing a treatment program

Ask what has changed. Is the medicine no longer helping as expected? Are there unwanted effects? Is the person taking more than prescribed, using someone else’s medication or obtaining tablets outside a pharmacy? Are they worried about what happens when a dose is missed?

Write the concern in neutral language. ‘I have been taking it differently from the prescription and I need advice’ gives a clinician useful information. ‘I am an addict’ may express fear, but it does not explain the clinical situation.

A family should avoid treating every prescription as evidence of misuse. Equally, the fact that a substance began as a legitimate medicine does not make every pattern of use safe. Assessment needs the actual history and current circumstances.

Physical dependence is not the same as addiction

Some medicines can produce physical dependence even when taken as directed. The FDA’s benzodiazepine safety communication distinguishes concerns about misuse, addiction, physical dependence and withdrawal, and warns that abrupt stopping or rapid reduction can cause serious withdrawal reactions. [2]

This distinction matters because shame can make people conceal symptoms or change medication without advice. Tell the prescriber what is happening and ask for an explanation of the risks and options in your situation.

Do not use this general information to decide whether a particular medicine should be continued, reduced or stopped. Different medicines and circumstances require different plans. A clinician needs to consider duration, dose, other substances, medical history and current symptoms.

Prepare a complete medication list

Record the name of each medicine, the prescribed instructions and how it is actually being taken. Include over-the-counter products, supplements, alcohol and other substances. Where something is unknown, say so rather than guessing.

Bring packaging or a prescription record if safely available. Explain any use from sources other than a regulated pharmacy. A tablet’s appearance or the name given by someone else does not reliably establish its contents; tell the clinician what you know and what you do not. [3]

Also note who is prescribing each medicine. When several clinicians are involved, ask who will coordinate the review. The assessment guide can help organize the history into a concise document.

When the situation needs urgent care

Severe drowsiness, difficulty waking, breathing problems, seizures, collapse or suspected overdose require emergency help. Contact local emergency services and follow their instructions. Do not wait for the usual prescriber to reply or assume the person will recover after sleeping. [4]

Tell responders which medicines or substances may be involved and when they were taken. Do not delay care while trying to obtain a complete account. The immediate priority is safety, not deciding whether the behavior was intentional or assigning blame.

Severe withdrawal symptoms or a sudden marked change in mental state also need urgent assessment. A private admissions enquiry is not an appropriate emergency route. Use the urgent-help page for relevant starting points.

Discuss the original reason for the prescription

A medication review should not focus only on stopping a substance. Ask how the original concern will be managed: pain, insomnia, anxiety, ADHD or another condition may still require treatment. Removing one element without a replacement plan can leave important needs unanswered.

Describe what benefit the person experiences and what worries them. A young adult may fear losing the ability to study; a teenager may worry that speaking honestly will mean being judged. Those concerns should be part of the clinical conversation.

Ask the prescriber to explain the options, uncertainties and monitoring arrangements. A useful plan connects medication decisions with psychological, medical or practical support where appropriate, rather than leaving the person to manage the underlying problem alone.

Stimulants, academic pressure and ADHD care

Taking prescribed ADHD medication under clinical supervision is not the same as using someone else’s medication to study. NIDA identifies misuse as including taking a prescription medicine differently from instructions, taking someone else’s prescription or using it for its effects rather than the prescribed purpose. [1]

A student worried about performance should discuss workload, sleep and support rather than experiment with medication. If a prescribed medicine is not working as expected, arrange a review instead of increasing it independently.

The ADHD guide explains how practical support and medication monitoring can fit together. A treatment conversation should not require the person to choose between receiving legitimate care and acknowledging concerns about misuse.

Sleep and anxiety medicines require specific advice

When a medicine is being used for sleep or anxiety, ask how long it was intended to be used, who reviews it and what follow-up is planned. Tell the clinician about alcohol or other sedating substances. Do not assume that combining products is safe because each was obtained separately.

For benzodiazepines, the FDA specifically warns about serious risks involving other central nervous system depressants and about withdrawal with abrupt discontinuation. [2] Ask the prescriber to explain what those warnings mean for the individual rather than attempting to construct a reduction schedule from general information.

Discuss the ongoing sleep or anxiety difficulty at the same appointment. A complete plan addresses both medication safety and the problem the person was trying to manage.

Ages 16-17: adolescent assessment and family involvement

Confirm that the clinician or service works with adolescents and can explain consent, confidentiality and safeguarding. Parents may need to provide prescription history or practical help, while the teenager needs an opportunity to speak honestly without a public confrontation.

Ask how medication will be managed across home, school or boarding arrangements. Who stores and administers it when relevant? Who notices missed reviews? Who contacts the prescriber if there are concerns? The answers should follow professional advice and local rules, not assumptions.

Do not remove prescribed medication abruptly as a punishment. If misuse or safety is suspected, seek clinical advice promptly and ask how to manage access safely. The priority is an appropriate assessment and plan.

Ages 18-25: multiple prescribers and changing locations

Young adults may receive care from university health services, private clinicians and doctors near the family home. Ask how those providers communicate and which person has an accurate medication list. With appropriate consent, coordination can reduce gaps and conflicting instructions.

Before travel or a move, check prescribing arrangements and any applicable rules with the relevant professionals and authorities. Do not assume a prescription is automatically transferable across borders or that a clinician can continue remote prescribing everywhere.

Family help should be agreed. A parent can assist with booking a review or gathering records without automatically receiving all clinical information. See privacy and family involvement for questions to clarify with the treating service.

What specialist support may involve

Depending on assessment, support may include a medication review, treatment for a substance use disorder, psychological work, management of the original condition or a medically supervised withdrawal plan. Ask which elements are actually indicated and who is qualified to deliver them. [1]

A service should explain its limits. Can it manage the relevant medicine and level of medical risk? Is a hospital or specialist addiction service needed? What happens if symptoms become more complex than expected?

Avoid programs that promise a universally rapid detox or describe every prescribed medicine as a toxin to eliminate. Ask for an individualized rationale, informed consent and a clear monitoring plan rather than a fixed package based only on marketing language.

Comparing settings and costs

Outpatient care, day treatment, residential services and hospitals offer different capabilities. Ask the assessing clinician what setting is appropriate before comparing accommodation or price. A residential program is not necessarily equipped for every withdrawal or medical presentation.

Request a written explanation of medical cover, prescribing responsibility, emergency transfer and what is included in fees. Clarify external consultations, tests and follow-up costs. The costs and funding guide provides a structure for this discussion.

For a minor, verify adolescent eligibility for the specific facility. For a young adult, ask how treatment will connect with the clinician who will provide ongoing care after discharge.

A constructive family conversation

Begin with a concrete concern and an offer of help: ‘I am worried about the way the medication is being used. Can we arrange a review with someone qualified to advise?’ Avoid threats to expose the person or demands to stop immediately without medical advice.

An illustrative example: a student admits using tablets supplied by a friend during examinations. A useful response is to arrange a healthcare assessment, explain the uncertainty about contents and discuss academic pressure. The response should address safety and the underlying situation, not only discipline.

Agree how practical support will work while the review is arranged. If immediate safety is uncertain, seek urgent care rather than relying on a future promise or a family agreement alone.

Frequently asked questions

Does physical dependence prove addiction?

No. Physical dependence can occur with some prescribed medicines and is not identical to an addiction diagnosis. A clinician should assess the pattern, risks and appropriate next steps. Do not use either term as a substitute for a medication review. [2]

Should someone stop a worrying medicine immediately?

Not without appropriate advice, unless an emergency clinician instructs otherwise. Abrupt changes can be dangerous for some medicines. Contact the prescriber promptly and use urgent care for severe symptoms or suspected overdose.

What if the person is afraid to tell the doctor?

A short written account can help: what was prescribed, what was actually taken and what the concern is now. Ask about confidentiality and the assessment process. Accurate information is essential to a safe plan.

What is the most useful first action?

Arrange a medication review, prepare a complete list and identify urgent symptoms. Do not attempt a self-directed detox or purchase replacement medicines from unverified sources while waiting for advice.

Sources and further reading

  1. NIDA — Misuse of prescription drugs
  2. FDA — Benzodiazepine boxed warning
  3. FDA — Counterfeit medicine
  4. CDC — Reversing overdose with naloxone